Publications by authors named "K Besseghir"

Claim this Profile
I
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
Roger G Ptak, Philippe A Gallay, Dirk Jochmans, Andrew P Halestrap, Urs T Ruegg, Kamel Besseghir

Antimicrob Agents Chemother· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
J L Bourges, F Lallemand, E Agla, K Besseghir, J M Dumont

Mol Vis· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.
Udayan Chatterji, Michael D Bobardt, Robyn Stanfield, Roger G Ptak, Luke A Pallansch, Kamel Besseghir

J Biol Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
Frederic Lallemand, Philippe Perottet, Olivia Felt-Baeyens, Werner Kloeti, Florence Philippoz, Kamel Besseghir

Eur J Pharm Sci· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
F Lallemand, P Furrer, O Felt-Baeyens, M Gex-Fabry, J-M Dumont, K Besseghir

Int J Pharm· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis